FI970717A - Methods for inhibiting uterine cancer - Google Patents

Methods for inhibiting uterine cancer Download PDF

Info

Publication number
FI970717A
FI970717A FI970717A FI970717A FI970717A FI 970717 A FI970717 A FI 970717A FI 970717 A FI970717 A FI 970717A FI 970717 A FI970717 A FI 970717A FI 970717 A FI970717 A FI 970717A
Authority
FI
Finland
Prior art keywords
methods
uterine cancer
inhibiting uterine
inhibiting
cancer
Prior art date
Application number
FI970717A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI970717A0 (en
Inventor
Susan Margaret Boss
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI970717A publication Critical patent/FI970717A/en
Publication of FI970717A0 publication Critical patent/FI970717A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FI970717A 1994-08-22 1997-02-20 Methods for inhibiting uterine cancer FI970717A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29385394A 1994-08-22 1994-08-22
PCT/US1995/010651 WO1996005833A1 (en) 1994-08-22 1995-08-21 Methods of inhibiting endometrial cancer

Publications (2)

Publication Number Publication Date
FI970717A true FI970717A (en) 1997-02-20
FI970717A0 FI970717A0 (en) 1997-02-20

Family

ID=23130867

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970717A FI970717A0 (en) 1994-08-22 1997-02-20 Methods for inhibiting uterine cancer

Country Status (17)

Country Link
EP (1) EP0777476A4 (en)
JP (1) JPH10504824A (en)
KR (1) KR970705387A (en)
AU (1) AU688112B2 (en)
CA (1) CA2198119A1 (en)
CZ (1) CZ51897A3 (en)
FI (1) FI970717A0 (en)
HU (1) HUT76890A (en)
IL (1) IL115022A (en)
MX (1) MX9701327A (en)
MY (1) MY113757A (en)
NO (1) NO970783D0 (en)
NZ (1) NZ292017A (en)
RU (1) RU2161964C2 (en)
TW (1) TW404834B (en)
WO (1) WO1996005833A1 (en)
ZA (1) ZA956994B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856340A (en) * 1995-02-28 1999-01-05 Eli Lilly And Company Method of treating estrogen dependent cancers
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
KR20160066490A (en) * 2014-12-02 2016-06-10 주식회사 씨앤드씨신약연구소 Heterocyclic derivatives and use thereof
CN115825414B (en) * 2023-01-09 2023-04-25 中国医学科学院北京协和医院 Blood or urine metabolic marker and application thereof in endometrial cancer early screening

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
JP3157882B2 (en) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 New benzothiophene derivatives
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
CA2160135A1 (en) * 1993-04-07 1994-10-13 Donald P. Mcdonnell Method for screening for receptor agonists
CA2118096A1 (en) * 1993-10-15 1995-04-16 Srinivasan Chandrasekhar Methods for treating resistant neoplasms
HUT76854A (en) * 1994-08-22 1997-12-29 Lilly Co Eli Use of benzotiophene derivatives for production of pharmaceutical compositions inhibiting primary endometrial hyperplasia
US5843964A (en) * 1994-09-22 1998-12-01 Eli Lilly And Company Methods of inhibiting endometrial mitoses

Also Published As

Publication number Publication date
WO1996005833A1 (en) 1996-02-29
NO970783L (en) 1997-02-20
MX9701327A (en) 1997-05-31
IL115022A (en) 2000-07-31
NO970783D0 (en) 1997-02-20
NZ292017A (en) 2000-07-28
HUT76890A (en) 1997-12-29
AU3370095A (en) 1996-03-14
CA2198119A1 (en) 1996-02-29
CZ51897A3 (en) 1997-06-11
RU2161964C2 (en) 2001-01-20
KR970705387A (en) 1997-10-09
EP0777476A1 (en) 1997-06-11
FI970717A0 (en) 1997-02-20
ZA956994B (en) 1997-02-21
MY113757A (en) 2002-05-31
TW404834B (en) 2000-09-11
JPH10504824A (en) 1998-05-12
IL115022A0 (en) 1998-06-15
EP0777476A4 (en) 1999-06-23
AU688112B2 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
DK0770169T3 (en) Hydrate inhibition
FI963597A (en) Isoprenyylitransferaasi inhibitors
NO972930D0 (en) Fibronectin-adhesion inhibitors
FI972160A (en) Matriisimetalloproteaasi inhibitors
NO962901L (en) Procedure for single trip completion
BR9509436A (en) Apoliprotein-B synthesis inhibitors
NO301445B1 (en) Towing device
ID19075A (en) CAPACIC PLACES FOR ASETALDEHIDA
IS5035A (en) Methods for the prevention of breast cancer
NO305341B1 (en) Electro-fishing device
DE69508378D1 (en) MULTI-CHANNEL RADAR
IDP000008233A (en) BREAST CANCER PREVENTION METHOD
FI970717A (en) Methods for inhibiting uterine cancer
FI971197A0 (en) Methods for inhibiting uterine mucosal mitoses
KR960000746U (en) Cutter for cutter
KR960010058U (en) slide
KR950029048U (en) Straightener suppressor
ATA212094A (en) ROAD GUIDE
KR950024712U (en) Fast-reading letterpress
UA1534S (en) UNDERWEAR - GRACE FOR WOMEN
KR950027027U (en) For albums
SE9402900D0 (en) slide Way
NO964439L (en) For
NO960756D0 (en) For
UA27887C2 (en) DEVICE FOR REFLEXOTHERAPY